Neurodyn Life Sciences Inc. — Form D
Neurodyn Life Sciences Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2014-09-25. The offering totals $349K, of which $349K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-09-25
- Form: D
- Accession: 0001140361-14-036469
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $349K
- Amount sold: $349K
- Investors: 1
- Date of first sale: 2014-01-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-225331
Issuer
- Name: Neurodyn Life Sciences Inc.
- CIK: 0001568852
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 439 Helmcken Street, VANCOUVER, A1, V6B 2E6
- Phone: 604-684-3323
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Denis A Kay | Director | York, A7 |
| Denis A Kay | Executive Officer | York, A7 |
| Kenneth A Cawkell | Director | Vancouver, A1 |
| Kenneth A Cawkell | Executive Officer | Vancouver, A1 |
| James L Mertz | Director | Vancouver, A1 |
| Robert L Cervelli | Director | Vancouver, A1 |
| Madolyn L Mertz | Director | Vancouver, A1 |
| Richard L Devries | Director | Vancouver, A1 |
| Denis G Kay | Director | Vancouver, A1 |
| Denis G Kay | Executive Officer | Vancouver, A1 |
| Alfred L Maelicke | Director | Neider-Olm, 2M |
| Len L Mertz | Director | San Angelo, TX |
| Robert A Cervelli | Director | Vancouver, A1 |
| Scott A Homenick | Executive Officer | Vancouver, A1 |
| James A Mertz | Director | Vancouver, A1 |
Other filings by this issuer (9)
More